AstraZeneca
AZN
#48
Rank
โ‚ฌ240.15 B
Marketcap
77,46ย โ‚ฌ
Share price
-0.66%
Change (1 day)
24.02%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ240.15 Billion

As of December 2025 AstraZeneca has a market cap of โ‚ฌ240.15 Billion. This makes AstraZeneca the world's 48th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ240.15 B21.64%
2024โ‚ฌ197.42 B4.54%
2023โ‚ฌ188.85 B-3.71%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-3.8%
2011โ‚ฌ46.06 B-5.85%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of AstraZeneca was reported to be:

โ‚ฌ241.80 Billion
by Nasdaq info icon info icon
โ‚ฌ241.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Bristol-Myers Squibb
BMY
โ‚ฌ88.64 B-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ125.34 B-47.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ210.07 B-12.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ84.37 B-64.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ101.57 B-57.71%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
โ‚ฌ774.67 B 222.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ431.85 B 79.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ183.20 B-23.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ22.40 B-90.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ217.61 B-9.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland